Shares of Eli Lilly & Co. dropped over 7% on Tuesday morning, reaching levels last seen in late November and marking the ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

We recently published an article titled Jim Cramer Discussed These 21 Stocks As Bond Yields Soared. In this article, we are ...

Its 60% US stock weight within the stock portfolio is about 3 percentage points below their weight in the global stock market. We’ll be keeping a close eye on how the team navigates this going ...

Investing.com -- Shares of Wyndham climbed 2.5% after Wells Fargo (NYSE: WFC) Securities upgraded the hotel operator to ...

Discover key support and resistance levels for MicroStrategy with insights on valuation and market movements based on ...

Note :Financial Information is based on consolidated numbers.

Following a production update, Roth MKM analyst Darren Aftahi has maintained his “Buy” rating on Bitdeer Technologies.

Stock ratings can range from simple “buy” and “sell” ratings to “equal weight” and “outperform” ratings. Here’s a quick overview of how analysts rate stocks. A “buy” rating ...

An equal-weight measure of the S&P 500 was rising Thursday afternoon, even as major U.S. stock indexes traded down. The Invesco S&P 500 Equal Weight ETF, which tracks an index that equally weights ...

Morgan Stanley downgraded Confluent (CFLT) to Equal Weight from Overweight with a price target of $30, down from $33. While the company’s data ...

(Reuters) -Weight-loss drug developer Metsera ... Metsera intends to list its shares on the Nasdaq Global Market under the ...